NGeneBio Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,971	4,430	19,275	24,897	16,296
Short-Term Investments	8.08	58.42	129.05	10,021	8,011
Trading Asset Securities	3,031	3,008	3,023	-	-
Cash & Short-Term Investments	5,010	7,496	22,427	34,918	24,307
Cash Growth	-69.61%	-66.57%	-35.77%	43.66%	-
Accounts Receivable	707.94	699.76	788.95	1,125	1,574
Other Receivables	157.16	62.06	210.77	51.09	58.06
Receivables	865.1	761.82	999.72	1,176	1,632
Inventory	1,879	2,074	1,695	2,968	1,219
Prepaid Expenses	64.77	120.57	121.5	141.72	79.67
Other Current Assets	1,164	1,220	1,779	3,868	136.73
Total Current Assets	8,983	11,672	27,021	43,072	27,374
Property, Plant & Equipment	11,298	12,172	9,343	8,684	8,092
Long-Term Investments	1,057	1,057	2,837	1,378	5,451
Goodwill	5,376	5,388	416.32	416.32	416.32
Other Intangible Assets	2,335	2,427	1,456	1,224	1,247
Other Long-Term Assets	232.82	233.05	1,208	1,389	1,287
Total Assets	29,282	32,950	42,282	56,164	43,867
Accounts Payable	65.27	376.67	162.75	69.18	172.85
Accrued Expenses	541.36	476.88	253.59	235.99	188.37
Short-Term Debt	6,875	6,750	11,056	10,786	6,100
Current Portion of Long-Term Debt	-	-	-	-	362
Current Portion of Leases	924.29	1,028	241.11	295.95	161.89
Current Unearned Revenue	-	-	0	20.17	18.33
Other Current Liabilities	3,684	3,893	12,103	17,594	1,051
Total Current Liabilities	12,090	12,525	23,816	29,001	8,055
Long-Term Debt	-	-	-	-	500
Long-Term Leases	1,014	1,242	146.88	374.62	82.69
Other Long-Term Liabilities	10.17	10.19	150.52	165.38	43.69
Total Liabilities	14,566	15,241	26,048	30,837	9,869
Common Stock	19,819	19,819	12,889	12,526	12,431
Additional Paid-In Capital	61,213	60,909	55,102	52,570	51,982
Retained Earnings	-69,031	-66,297	-53,941	-40,886	-31,381
Comprehensive Income & Other	2,277	2,547	2,244	1,086	965.73
Total Common Equity	14,278	16,977	16,295	25,297	33,998
Minority Interest	437.92	731.71	-60.68	30.24	-
Shareholders' Equity	14,716	17,709	16,234	25,327	33,998
Total Liabilities & Equity	29,282	32,950	42,282	56,164	43,867
Total Debt	8,813	9,019	11,444	11,456	7,207
Net Cash (Debt)	-3,803	-1,523	10,983	23,462	17,100
Net Cash Growth	-	-	-53.19%	37.20%	-
Net Cash Per Share	-238.96	-91.44	865.85	1880.24	1382.64
Filing Date Shares Outstanding	19.82	19.82	12.89	12.53	12.43
Total Common Shares Outstanding	19.82	19.82	12.89	12.53	12.43
Working Capital	-3,107	-852.15	3,205	14,072	19,319
Book Value Per Share	720.44	856.62	1264.22	2019.58	2734.94
Tangible Book Value	6,567	9,162	14,422	23,656	32,334
Tangible Book Value Per Share	331.35	462.28	1118.95	1888.61	2601.11
Land	2,696	2,696	2,696	2,584	2,584
Buildings	4,044	4,044	4,044	3,040	3,040
Machinery	8,191	8,422	4,962	4,569	3,699
Construction In Progress	-	-	-	9.23	-

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.